“…Crystallization is a key operation in pharmaceutical production, and a number of continuous crystallization platforms have been demonstrated to be viable, with sufficiently robust operation, while being capable of commercial levels of supply . Continuous stirred tank reactors (CSTRs), mixed suspension mixed product removal (MSMPR) crystallizers, and tubular and oscillatory flow crystallizers have been demonstrated to be able to monitor, characterize, model, and control all important crystal product attributes for pharmaceuticals such as crystal size distribution (CSD), ,,,− morphology, ,, chemical purity, ,, yield, ,,, chirality, or polymorphic purity. − …”